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Background: Analyses of relative effectiveness of 1st generation drug-eluting stents vs bare metal stents (BMS) concluded that drug-eluting stents 
should be used only for stented diameters <3.0 mm and lengths ≥15 mm, and at a cost differential of <$500. Whether similar recommendations 
would be supported with newer generation everolimus-eluting stents (EES) is unknown.
methods: Single-lesion percutaneous coronary interventions with BMS (n=600) and EES (n=741) were performed at a single center (Wake Forest 
Baptist Medical Center) between January 2007 and December 2010. One year clinical outcomes and costs were compared between propensity 
score matched cohorts (n=555 for each), with complete 1-year follow-up >94% for each. All costs were in 2012 US dollars, including generic 
clopidogrel ($1/day).
results: Matched baseline characteristics were similar for EES vs BMS (all standardized differences <10%). Clopidogrel use at 1-year was 87% EES 
vs 61% BMS (p<0.001). EES reduced target lesion revascularization (TLR) vs BMS (-5.0%, p<0.001) and 1-year aggregate costs were $241 more for 
EES ($769 less to $1,281 more) vs BMS. Aggregate 1-year costs and cost effectiveness ratios stratified by stented length and diameter are shown in 
the figure.
conclusions: EES reduced TLR and was cost effective vs BMS across stented length and diameter stratifications. These observations suggest that 
selective stent strategies based on diameter and length may result in suboptimal utilization.
